16 September 2026 Biologics Clinical research Hidradenitis Suppurativa IBD risk stays low with IL-17 inhibitors in HS
2 September 2026 Biologics Clinical research Hidradenitis Suppurativa Evaluating the cost and efficacy of HS biologics
2 September 2026 Biologics psoriatic arthritis Research Oral TYK2 inhibitor holds PsA gains to one year
24 June 2026 Biologics psoriatic arthritis Bimekizumab outperforms risankizumab in head-to-head PsA trial
18 March 2026 Biologics Clinical research Hidradenitis Suppurativa Tunnels tip the balance in hidradenitis suppurativa
